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 2 
Abstract 28 
Cognitive malfunction, synaptic dysfunction, and disconnections in neural networks are core 29 
deficits in Alzheimer’s disease (AD). 5xFAD mice, a transgenic model of AD, are characterised by 30 
an enhanced level of amyloid-beta and abnormal neurotransmission. The dopaminergic (DA) 31 
system has been shown to be involved in amyloid-beta transformations and neuronal plasticity; 32 
however, its role in functional network changes in familial AD still remains unclear. In 5xFAD and 33 
non-transgenic freely moving mice, electroencephalograms (EEGs) were simultaneously 34 
recorded from the secondary motor cortex (MC), superficial layers of the hippocampal CA1 area 35 
(HPC), substantia nigra (SN), and ventral tegmental area (VTA). EEGs and their frequency 36 
spectra were analysed before and after systemic injection of a DA receptor agonist, apomorphine 37 
(APO). In the baseline EEG from MC and HPC of 5xFAD mice, delta and alpha oscillations were 38 
enhanced and beta activity was attenuated, compared to control mice. In VTA and SN of 5xFAD 39 
mice, delta-theta activity was decreased and beta oscillations dominated. In control mice, APO 40 
suppressed delta activity in VTA to a higher extent than in MC, whereas in 5xFAD mice, this 41 
difference was eliminated due to attenuation of the delta suppression in VTA. APO increased 42 
beta activity in MC of mice from both groups while significant beta suppression was observed in 43 
VTA of 5xFAD mice. These mice were characterized by significant decrease of tyrosine 44 
hydroxylase immunopositive cells in both VTA and SN and of DA transporter in MC and 45 
hippocampal dentate gyrus. We suggest that the EEG modifications observed in 5xFAD mice are 46 
associated with alterations in dopaminergic transmission, resulting in adaptive changes in the 47 
cerebral networks in the course of familial AD development. 48 
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1. Introduction 53 
 Alzheimer's disease (AD), characterized by neurodegeneration, pathological formation of 54 
extracellular amyloid plaques and intraneuronal aggregation of hyperphosphorylated tau into 55 
neurofibrillary tangles in the brain, is associated with a gradual decline of cognitive abilities (for 56 
review, see [1]). Synaptic dysfunction and an imbalance between coordinated activities of 57 
different brain structures is hypothesized to be the main cause of abnormal functioning of the 58 
diseased brain [2 - 5]. Cognitive decline in AD is thought to be associated with alterations in 59 
synaptic transmission and thus in neuronal network function that is accompanied by modification 60 
of oscillations in the affected circuits [6, 7]. Superimposed extracellular fields arising from 61 
synaptic transmembrane currents of neurons involved in the circuits are supposed to form the 62 
electroencephalogram (EEG) [8] whose frequency composition has been shown to be associated 63 
with cognitive abilities of AD patients [9]. Substantial changes in the interhemispheric asymmetry 64 
in cortical EEG frequency spectra, demonstrated in AD patients [10], are in line with the well-65 
known role of interhemispheric transfer for effective learning and memory [11]. Furthermore, 66 
changes in EEG recorded from the frontal cortex and/or the hippocampus, key brain areas in 67 
learning and memory processing, have been shown in an amyloid rat model of AD [12] and in 68 
numerous transgenic mouse models of AD [13 - 19].  69 
 Among transgenic mice, the 5xFAD line is distinguished by expressing multiple familial AD 70 
(FAD) mutations that additively increase amyloid-beta42 (Aβ42) production, the main hallmark in 71 
AD, and by causing dissociation between cortical and hippocampal synaptic plasticity [20], 72 
changes in cortical excitability and hippocampal rhythmicity, and defects in cholinergic 73 
transmission [18]. 5xFAD mice have been shown to exhibit intraneuronal Aβ accumulation at 1.5 74 
months, Aβ deposition at 2 months, and memory deficits at 4 months of age [21] that are 75 
accompanied by defects in synaptic vesicle dynamics and neurotransmitter release [22]. Despite 76 
a significant Aβ accumulation, the overall numbers of neurons in the frontal cortex and 77 
hippocampus in 5xFAD mice have been shown to equal those in age-matched controls, with the 78 
exception of a neuronal loss in cortical layer 5 [23]. Interestingly, before this specific structural 79 
dystrophy, synaptic deficits in layer 5 neurons were observed [24]. Thus, a deeper insight into the 80 
activities of different brain networks and their changes in the 5xFAD mice promises to aid 81 
effective analysis of the AD pathogenesis [18]. 82 
 In a number of recent studies on AD transgenic mice (and 5xFAD, in particular), substantial 83 
attention has been paid to neuronal networks within/between the cortex and the hippocampus 84 
[12, 17 - 20, 25, 26]. Furthermore, the role of cholinergic, monoaminergic, and GABA-ergic 85 
transmission in the functioning of these networks has been shown [18, 25, 27]. In our previous 86 
study on an amyloid AD model, involvement of the dopaminergic (DA) system in the cortex-87 
hippocampus EEG interplay has been revealed [12]. However, we are still lacking detailed 88 
information how this system is affected in the AD transgenic mice. This needs to be clarified 89 
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given data demonstrating a role of the DA system in both neuronal plasticity and amyloid-beta 90 
transformations in AD [28 - 30].  91 
 In this study on 5xFAD and non-transgenic (control) adult mice, we recorded EEGs from the 92 
secondary motor cortex, dorsal hippocampus, and from two DA-producing areas, the substantia 93 
nigra and ventral tegmental area, before and after systemic injection of a DA receptor agonist, 94 
apomorphine. Significant differences between 5xFAD and control mice were revealed in 95 
frequency spectra of both baseline and APO-evoked EEG activities in and between the brain 96 
areas.  97 
 98 
2. Materials and Methods 99 
 Twelve six-month old male transgenic (Tg) mice with five familial AD mutations (5xFAD mice, 100 
B6SJL-Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/J) were maintained on the C57BL/6J 101 
genetic background and fifteen non-transgenic (nTg, wild type control) littermates were used in 102 
this study. The 5xFAD mice were originally obtained from the Center for Collective Use of the 103 
Institute of Physiologically Active Compounds RAS (Chernogolovka, Russian Federation). Up to 104 
the age of five months, the mice were housed in groups of five per cage, while, thereafter, each 105 
of them was kept for 1.5 months in an individual cage. Mice were housed in a standard 106 
environment (12-h light/dark cycle, 22-25°C room temperature, 50-55% relative humidity) with 107 
food and water ad libitum. The procedures were carried out in accordance with the “Guidelines 108 
for accommodation and care of animals. Species-specific provisions for laboratory rodents and 109 
rabbits” (GOST 33216-2014) and in compliance with the principles enunciated in the Directive 110 
2010/63/EU on the protection of animals used for scientific purposes, and approved by the local 111 
Institute Ethics Review Committee. All efforts were made to minimize both the number of the 112 
animals and their suffering. 113 
 All mice were genotyped using PCR analysis of DNA obtained from the ear/tail biopsy, 114 
followed by separation of the reaction products in the agarose gel. Mice with a transgene 115 
cassette in the genome were combined into Tg group, whereas those with lacking transgene 116 
were placed into nTg group. Post-mortem verification of the amyloid plaques in the brain slices 117 
(Suppl. 1), stained with thioflavin-S [32], revealed this AD hallmark in all mice from the Tg group. 118 
2.1. Electrodes implantation and EEG recording 119 
 After one month of adaptation to the individual cage, each of six 5xFAD mice (29.7 ± 0.5 g) 120 
and nine nTg mice (33.0 ± 1.1 g) was anesthetized with subcutaneous (s.c.) injection of a 121 
combination of dissolved tiletamine/zolazepam (Zoletil®, Virbac, France) and xylazine solution 122 
(Rometar®, Bioveta, Czech Republic) at doses of 25 mg/kg and 2.5 mg/kg, respectively. Four 123 
recording electrodes were implanted into the left secondary motor cortex (MC; AP: +1.9, ML: -0.4, 124 
DV: -2.0), over the left dorsal hippocampus (HPC; AP: -2.8, ML: -2.7, DV: -1.7), into the left 125 
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ventral tegmental area (VTA; AP: -3.1, ML: -0.4, DV: -4.5), and into the right substantia nigra (SN; 126 
AP: -3.2, ML: +1.3, DV: -4.3) [33] (DV was measured from the skull surface). Within areas 127 
analyzed in this study, the opposite hemisphere for SN was chosen, firstly, because of its 128 
proximity to VTA which meant we could not exclude possible mutual damage during electrode 129 
implantation in the same hemisphere. Secondly, it is well known that the contralateral SN is the 130 
dominant source of DA in the opposite (here: left) hemisphere. Custom made electrodes were 131 
constructed from two varnish-insulated nichrom wires (100-µm diameter) glued together (3M 132 
VetbondTM Tissue Adhesive, MN, USA) with tips free from insulation for 100 µm. Thus, prepared 133 
electrodes were sufficiently inflexible, and had higher effective surface/volume ratio than a mono-134 
wire electrode of 200-µm diameter. The reference and ground electrodes (stainless steel wire, 0.4 135 
mm in diameter) were placed symmetrically into the caudal cavities behind the cerebrum (AP: -136 
5.3, ML: ±1.8, DV: -0.5). All electrodes were positioned using a computerized 3D stereotaxic 137 
StereoDrive (Neurostar, Germany), fixed to the skull with dental cement and soldered to a dual 138 
row female connector (Sullins Connector Solutions, CA, USA). Both nichrom wires of the deep 139 
electrode were soldered to one of the connector's pins. After electrode implantation, animals were 140 
housed individually. Post-mortem verification of the electrode tip location included several steps: 141 
an anodal current (80-100 µA, 1 s) coagulation of the adjacent tissue, extirpation of the brain and 142 
fixation of the cerebrum in 4% paraformaldehyde. The brain was cut in 30-µm sections using a 143 
freezing microtome (Reicher, Austria). Coronal sections were examined to specify the electrode 144 
tip locations; EEG recordings from those, which did not meet placement criteria, were excluded 145 
from further analysis. Effective electrode targeting of the chosen brain areas was based on the 146 
use of the stereotaxic manipulator and on precise measurement of bregma and lambda 147 
coordinates. This high-tech manipulator allows the drilling of the holes for the electrodes exactly 148 
in the selected points on the skull. Precise estimations of an individual’s bregma-lambda distance 149 
provides the correction of the coordinates for the brain areas, taking into account that  the value 150 
used for preparation of the stereotaxic atlas [33] was equal to 4.2±0.25 mm. In several cases, 151 
when the electrolytic marker was relatively enlarged, the electrode tip position was assigned to 152 
the point where the effect of electrolysis within the coagulated area was maximal. The frozen 153 
slices with the most effective electrode position were Nissl stained with cresyl violet acetate [34], 154 
magnified (Nikon Eclipse E200 microscope, Japan), digitized (DXM1200 camera, Japan), and 155 
used for illustration in combination with corresponding images of the mouse brain atlas [31] 156 
(Suppl. 2). 157 
Three days after electrode implantation, each mouse was adapted for four days (1 h/day) to an 158 
experimental cage (Perspex, 15x17x20 cm) located in an electrically shielded chamber and to a 159 
cable (five 36-gauge wires, Plexon Inc, Texas, USA) plugged in a digital Neuro-MEP amplifier 160 
(Neurosoft Ltd, Ivanovo, Russian Federation). On day 8, a baseline EEG was recorded for 60 161 
min, starting 20 min after placing the animal into the box. EEG recordings were continued for 120 162 
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minutes after s.c. injection either saline (control) or, on the next day, apomorphine (APO, Sigma, 163 
Milan, Italy), at a dose of 1.0 mg/kg. To minimize the effect of oxidation only freshly dissolved 164 
APO was used. All experiments were performed from 9 am to 6 pm in daylight combined with an 165 
artificial light source keeping illumination at a relatively stable level. 166 
2.2. Computation of EEG frequency spectra 167 
Monopolar EEG signals measured between the active and reference electrodes were 168 
amplified, filtered (0.1-35 Hz) and sampled (1 kHz) on-line using the amplifier and kept in memory 169 
of an operational computer for further analysis. The frequency spectra of successive 12-sec EEG 170 
epochs were studied using a modified version of period-amplitude analysis [35], which, in 171 
contrary to the Fourier transform, was not affected by well-known non-stationary nature of the 172 
EEG signals. The absolute values of the half-wave amplitudes with periods/frequencies in each of 173 
selected narrow EEG frequency subbands were summed followed by their normalization to the 174 
summarized values. In this study, twenty subbands in the 0.48 - 26.25 Hz range were analyzed: 175 
0.48 - 0.53 (0.5), 0.87 - 0.97 (0.9), 1.29 - 1.43 (1.4), 1.74 - 1.92 (1.8), 2.21 - 2.44 (2.3), 2.71 - 3.0 176 
(2.9), 3.25 - 3.59 (3.4), 3.82 - 4.22 (4.0), 4.44 - 4.91 (4.7), 5.12 – 5.66 (5.4), 5.86 - 6.48 (6.2), 6.68 177 
- 7.38 (7.0), 7.59 - 8.39 (8.0), 8.63 - 9.54 (9.1), 9.83 – 10.86 (10.3), 11.25 - 12.43 (11.8), 12.98 - 178 
14.35 (13.7), 15.21 - 16.82 (16.0), 18.36 - 20.3 (19.3), 23.75 - 26.25 (25.0). The subbands are 179 
marked in figures by their centre (mean) frequency values (see in brackets, above). The terms 180 
“lower” and “higher” in “classical” EEG bands delta (0.5 - 3.6 Hz), theta (3.8 - 8.4 Hz), alpha (8.6 - 181 
12.4 Hz), and beta (12.9 - 26.2), are used below to differentiate corresponding frequency 182 
subbands of each band relative to its centre frequency (for more details, see [12]).  183 
The frequency spectra of 12-sec EEG epochs were averaged for every successive 10-min 184 
interval for each mouse and for all of them separately from nTg and Tg groups. Relative 185 
differences in the averaged EEG spectra, obtained in the experiments with saline (day 1) and 186 
APO (day 2) in each group, were estimated as (APO - Saline) / Saline, in percentages, which 187 
providing the evaluation of APO effects in nTg and Tg groups.  188 
2.3. Immunohistochemical techniques 189 
In additional groups of 5xFAD and nTg mice (n = 6 in each group), the animals were deeply 190 
anaesthetized with ether and transcardially perfused consecutively with ice-cold saline and 4% 191 
paraformaldehyde in phosphate-buffered solution (PBS). Afterwards, the brains were promptly 192 
removed from the cranium and kept in the paraformaldehyde/PBS solution at 4oC for further 193 
histochemical analysis. For each animal, coronal brain sections (20-µm thick) at the level of VTA 194 
and SN were prepared using a freezing microtome (Reicher, Austria) and stored at -20°C in a 195 
cryoprotective solution (30% glycerol, 30% ethylene glycol in 0.05M PBS). To evaluate tyrosine 196 
hydroxylase (TH) immunoreactive cell populations in VTA and SN the slices were washed with 197 
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water and subsequently incubated overnight with rabbit polyclonal anti-TH antibodies (1:500, 198 
Chemicon, Woburn, MA, USA). Afterwards, they were incubated for one hour at room 199 
temperature with biotinylated goat secondary antibodies against rabbit's immunoglobulin (1:200, 200 
Abcam, UK) and with avidin-biotin-peroxidase complex (1:400, Sigma, USA). Peroxide content in 201 
the slices was measured after their incubation in a composition of 3,3’-diaminobenzidine-202 
tetrahydrochloride (DAB; Sigma, St. Louis, USA) and H2O2 (at 0.05% and 0.02%, respectively) for 203 
3-3.5 min at 20°C, followed by washing with PBS and fixation on gelatine-coated glass slides. 204 
Images of the brain slices were magnified (20x) and digitized (Nikon Eclipse E200 microscope 205 
and DXM1200 camera, respectively, Japan) for the count of the DA-producing neurons in the 206 
VTA and SN borders outlined using the atlas of TH-positive cells distribution [36]. The number of 207 
tyrosine hydroxylase immunopositive (TH+) cells was manually counted inside of symmetrical 208 
VTA and SN contours on each slide. Within thirty consecutive sections at the level of VTA and 209 
SN, five of them (every sixth one) were used for this analysis. Thus, the total statistics data were 210 
based on 2 x 5 x 6 = 60 contours of VTA or SN, meaning two symmetrical areas on one slide, five 211 
slides, and six animals, respectively. Averaged data obtained on ten contours per mouse were 212 
used in the final statistics on all animals. 213 
The brain sections at the level of MC and HPC from the same mice were washed in PBS with 214 
Triton X100 and treated with H2O2 to inactivate endogenous peroxidase. They were consequently 215 
incubated with rabbit polyclonal anti-dopamine transporter antibody (MilliporeSigma, USA), with 216 
Biotin-conjugated goat secondary antibody (MilliporeSigma, USA), and, finally, with ExtraAvidin-217 
Peroxidase (Sigma, USA), all diluted 1:300. After staining with DAB (Sigma, USA) and mounting 218 
on the pre-coated glass slides (Superfrost-plus Menzel, Germany), the slices were cover-slipped 219 
(Coverquick, Labonord, France) and analyzed at magnification of 20x using the microscope 220 
(Nicon E200, Japan). Dopamine transporter (DAT) levels were assessed symmetrically in both 221 
MC and HPC (the dentate gyrus, CA1-CA2, and CA3-CA4 areas) in five coronal sections (every 222 
sixth of thirty ones) per animal. Digitized images of 0.25 mm2 in the target brain areas were 223 
analyzed by use of the Picture Analyzer Software, ImageJ, which estimated the DAB staining 224 
area. Averaged data obtained in ten 0.55 mm x 0.45 mm frames (0.25 mm2) per mouse were 225 
used in final statistics on all six animals. 226 
 227 
2.4. Statistics 228 
 Differences in the averaged EEG spectra were evaluated by a two-tailed non-parametric 229 
Mann-Whitney U-test for individual frequency subbands, and by ANOVA for repeated measures 230 
when progression of EEG effects in the frequency ranges was analyzed either separately in 231 
different brain areas (one-way ANOVA) or between them (2-way ANOVA). Immunohistochemical 232 
data were analysed by a two-tailed non-parametric Mann-Whitney U-test with Bonferroni 233 
correction. The group data were expressed as the means ± SEM; differences were considered 234 
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significant at p < 0.05. For ANOVA and U-test analyses, STATISTICA 10 (StatSoft, Inc., Tulsa, 235 
OK, USA) was used, whereas power and effect size were calculated by use of G*Power 3.1.9.4 236 
(www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3). At the effect size of 0.75 - 0.9 and 237 
power of 0.8, G*Power showed that the sample sizes chosen for nTg and Tg groups (9 and 6 238 
mice, respectively) were reasonable for our EEG study (see below). 239 
 240 
3. Results 241 
3.1. Baseline EEG from different brain areas 242 
During baseline EEG recordings, both non-transgenic (nTg) and transgenic (Tg) 5xFAD mice 243 
were behaviorally active and characterized by intensive exploration of the experimental box that 244 
was very rarely (1-2/60 min) interrupted by short (< 60 sec) sleep-like bouts.  245 
Baseline EEGs in freely moving and behaviourally active nTg and Tg (5xFAD) mice (Fig. 1 A 246 
and B, respectively) were characterized in MC and HPC by patterns of relatively slow (5 - 7 Hz) 247 
and very fast (14 - 25 Hz) oscillations. In the EEG from VTA, these patterns were also observed 248 
in Tg mouse, whereas powerful slow waves of 3 - 7 Hz were characteristic for nTg mouse. In the 249 
EEG from SN in nTg mouse, oscillations of 6 - 12 Hz predominated. The EEG patterns from MC 250 
and HPC were represented in their frequency spectra by peaks in theta and beta bands (Fig. 1, 251 
C, D). EEG spectra from VTA and SN in nTg mouse were characterized by wide peaks in the 252 
ranges of theta and theta-alpha, respectively, whereas, in Tg mouse, the peaks were found in the 253 
lower theta and higher alpha-beta (Fig. 1, E, F). These differences between the groups were 254 
stable in EEG spectra averaged over consecutive 10-min intervals and, thus, evidently observed 255 
in the spectral profiles that characterised the whole (60-min) baseline period (Fig. 2).  256 
In 5xFAD mice, EEG activity in MC was enhanced during this period in both delta and alpha 257 
bands and suppressed in beta band, compared to those in nTg mice (Fig. 2, A; 2-way ANOVA for 258 
15 samples x 6 repeats: F1,78 > 15, p < 0.001, for all bands). In HPC, the EEG differences in delta 259 
and beta bands between the groups were similar to those in MC (Fig. 2, B; 2-way ANOVA for 15 260 
samples x 6 repeats: F1,78 > 28, p < 0.001, for both bands). In VTA of 5xFAD mice, relatively slow 261 
oscillations in delta - theta range were attenuated, whereas beta activity was enhanced, 262 
compared to those in nTg mice (Fig. 2, C; 2-way ANOVA for 15 samples x 6 repeats: F1,78 > 34, p 263 
< 0.001, for both frequency ranges). In SN (Fig. 2, D), significant differences between 5xFAD and 264 
nTg mice were observed in the same frequency ranges (2-way ANOVA for 15 samples x 6 265 
repeats: F1,78 > 24, p < 0.001, for both ranges), however, the differences were evidently less than 266 
in VTA (c.f., Fig. 2, C and D, grey bars). All mentioned above differences were characterised by 267 
reasonable power and effect size measures (see Suppl. 3). 268 
Averaged EEG frequency spectra in MC were identical to those in HPC in both groups of mice 269 
(Fig. 3, A). EEG differences between VTA and SN (Fig. 3, B), enhanced in delta-theta range and 270 
reduced in beta band in nTg mice, were diminished in 5xFAD mice (2-way ANOVA for 15 271 
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samples x 6 repeats: F1,78 = 8.8, p < 0.01 and F1,78 = 6.3, p < 0.05, for both frequency ranges). In 272 
nTg mice, EEG differences between VTA and MC (Fig. 3, C, dotted line), increased in delta-alpha 273 
range and decreased in beta band, were reduced in 5xFAD mice (Fig. 3, C, solid line) (2-way 274 
ANOVA for 15 samples x 6 repeats: F1,78 > 270, p < 0.001, for both frequency ranges). The 275 
profiles of relative differences between EEG spectra in SN and MC in nTg mice (Fig. 3, D, dotted 276 
line) were similar to those observed between VTA and MC. In 5xFAD mice, the EEG spectral 277 
differences between SN and MC (Fig. 3, D, solid line) were significantly diminished in delta-alpha 278 
range and in beta band (2-way ANOVA for 15 samples x 6 repeats: F1,78 > 40, p < 0.001, for 279 
both). All mentioned above differences were characterised by reasonable power and effect size 280 
measures (see Suppl. 4). 281 
 282 
3.2. Apomorphine effects 283 
After APO injection, behavioral reactions of both Tg and nTg mice were stereotyped: short-284 
lasting freezing (1.5-2 min), followed by uninterrupted licking of the lower sides of the box that 285 
was accompanied by raising the tail. The behavioral response was comparable between Tg and 286 
nTg mice. Sleep-like bouts were very rare and short, and occurred at variable times.  287 
In several pilot/supporting experiments on four nTg and three Tg mice, variations in EEG 288 
spectra after saline injections in two consecutive days were evaluated. In spite of visible scattered 289 
fluctuations in the EEG spectra averaged over consecutive 10-min intervals, no significant 290 
regularities in the frequency-time domain were observed (see Suppl. 5). Given these preliminarily 291 
obtained findings and obvious advantage of the experimenting on the same mouse, the sequence 292 
of saline and APO injections in day 1 and day 2, respectively, was chosen as preferable. 293 
APO produced significant changes in cortical EEG activities in delta and beta bands (Fig. 4, A 294 
and B, respectively) compared to those observed after saline injection both in nTg mice (1-way 295 
ANOVA for 9 samples x 12 repeats: F11,96 = 3.8, p < 0.001 and F11,95 = 2.6, p < 0.05 for delta and 296 
beta bands, respectively) and in 5xFAD mice (1-way ANOVA for 6 samples x 12 repeats: F11,60 = 297 
3.3, p < 0.01 and F11,60 = 3.0, p < 0.01, for delta and beta bands, respectively). APO-induced 298 
delta suppression and beta enhancement in the cortex were observed for 50 min after injection 299 
and both were more powerfully expressed in 5xFAD mice, compared to those in nTg mice (2-way 300 
ANOVA for 15 samples x 5 repeats: F1,65 = 5.4, p < 0.05 and F1, 65 = 9.8, p < 0.01, for delta and 301 
beta bands, respectively). Similar APO effects revealed in hippocampal EEG (Fig. 4, C, D) 302 
evidently dominated for the whole 120-min period in 5xFAD mice over those in nTg mice in both 303 
delta and beta bands (2-way ANOVA for 15 samples x 12 repeats: F1,156 = 15.2, p < 0.001 and 304 
F1,155 = 24.5, p < 0.001, respectively). In EEG from VTA, APO suppressed delta activity for 50 305 
minutes to a similar extent in both groups (Fig. 4, E; 2-way ANOVA for 15 samples x 12 repeats: 306 
F1,156 = 0.8, p = 0.4). In contrast, beta activity was significantly enhanced in 5xFAD mice 307 
compared to that in nTg mice (Fig. 4, F; 2-way ANOVA for 15 samples x 12 repeats: F1,156 = 11.0, 308 
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p < 0.01). The profiles of APO effect in SN (Fig. 4, G, H) were similar to those observed in VTA. 309 
The main differences between APO effects in nTg and Tg mice were predominantly observed for 310 
50 minutes after APO injection and characterised by reasonable power and effect size measures 311 
(see Suppl. 6). 312 
After APO injection, the main interregional differences between the groups were revealed in 313 
MC and VTA (Fig. 5). In nTg mice, APO suppressed delta activity in VTA for 50 min after injection 314 
to significantly higher extent than in MC (Fig. 5, A). In 5xFAD mice (Fig. 5, B), this difference was 315 
eliminated predominantly due to its enhancement in VTA (c.f., Fig. 5, A and B, black lines; 2-way 316 
ANOVA for 12 samples x 12 repeats: F1,156 = 14.4, p < 0.001). After APO injection, beta activity in 317 
MC was increased for 50 minutes in both nTg and 5xFAD mice (Fig. 5, C and D, respectively, 318 
grey lines). In nTg mice, APO produced phasic response in beta activity in VTA that was tended 319 
to be lower relative to that in MC (Fig. 5, C, black and grey lines, respectively). In 5xFAD mice, 320 
beta activity in VTA was significantly suppressed by APO, compared to that in MC (Fig. 5, D; 2-321 
way ANOVA for 12 samples x 12 repeats: F1,156 = 10.7, p < 0.01). The differences in APO effects 322 
revealed in EEG from VTA and MC in nTg and Tg mice (Fig. 5, A and D, respectively) were 323 
characterised by reasonable power and effect size measures (see Suppl. 7). 324 
 325 
3.3. DA cells and dopamine transporter (DAT) distribution 326 
To investigate the impact of possible differences in the DA system in Tg and nTg mice on their 327 
EEG spectra, we stained brain sections with antibodies against TH or DAT at the levels of VTA-328 
SN or MC-HPC areas, respectively (see Materials and Methods). The approaches revealed a 329 
significant decrease of both TH-positive (TH+) cells in the DA-producing areas and DAT vesicle 330 
density in the forebrain areas in 5xFAD mice (Fig. 6, A, C and B, D, respectively).  331 
 332 
4. Discussion  333 
 In this study, we have shown significant differences between transgenic, 5xFAD, and non-334 
transgenic (nTg), control, mice in baseline and apomorphine-modified EEGs recorded from 335 
different brain areas: secondary motor cortex (MC), hippocampus (HPC), ventral tegmental area 336 
(VTA), and substantia nigra (SN).  337 
 Baseline EEG 338 
 In baseline EEG from MC and HPC in 5xFAD mice, delta and alpha oscillations were more 339 
powerfully expressed than in nTg mice whereas those in beta band were suppressed (Fig. 2, A, 340 
B). The increase of delta waves in the EEGs recorded from MC and HPC in 5xFAD mice seems 341 
to be typical for transgenic murine AD models, as slower EEG activity has been shown in 5xFAD, 342 
TgCRND8, and APP single mutant mice [13, 16, 18]. The EEG alterations in transgenic mice are 343 
thought to be linked to the Aβ accumulation and plaque formation [17, 19]. However, EEG 344 
modifications associated with the theta-gamma coupling, in particular, have been shown in 345 
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transgenic mice to precede the excessive Aβ production and other AD features [16]. In adult 346 
5xFAD mice, which have been shown to be characterized by typical AD indices (see, e.g., [21]), 347 
we demonstrate the slowing down of cortical and hippocampal oscillations in both theta-delta and 348 
beta-alpha ranges (Fig. 2, A, B). These effects seem to be associated with a significant 349 
suppression of DAT (Fig. 6, B, D) that might be expected to be associated with increase in DA in 350 
the synaptic cleft [37], which hypothetically is able to compensate, at least in part, for the loss of 351 
DA-producing neurones in VTA and SN (Fig. 6, A, C). The low level of DA receptor activation has 352 
been shown to be accompanied by EEG sleep features in the cortex [38]. Indeed, in 5xFAD mice, 353 
we observe a significant amplification of both delta and alpha oscillations in MC (Fig. 2, A), a 354 
hallmark of so-called "non-REM" sleep [39]. Transformation of theta and beta oscillations, which 355 
dominated in nTg mice, into a delta and alpha activities in 5xFAD mice suggesting the oscillatory 356 
circuits affected by excessive Aβ in transgenic mice have a potential for adaptive remodelling in 357 
response to the neurotoxicity of soluble Aβ [40], intraneuronal Aβ42-induced neurodegeneration 358 
and amyloid plaque formation, which are typical for 5xFAD mice [21]. Thus, further discovery of 359 
the mechanisms underlying reorganizing of disrupted neuronal circuits, involved, in particular, in 360 
sleep initiation might be useful for the development of a new therapeutic approach.  361 
 In EEG from VTA and SN in 5xFAD mice, averaged amplitudes of delta-theta waves were 362 
significantly decreased whereas those of beta rhythms were increased (Fig. 2, C, D). These 363 
frequency ranges coincide with those that characterise tonic (delta-theta) and so-called "bursting" 364 
(beta) neuronal activities in the DA-producing areas [41, 42]. Given these and an involvement of 365 
transmembrane currents in the origin of the EEG [8], the spectral differences in EEG from VTA 366 
and SN may be interpreted as a weakening of tonic spiking and strengthening of phasic bursting 367 
activity of DA neurones in 5xFAD mice. This is in line with an about four-fold higher rate of 368 
bursting patterns revealed in rats after long-term 6-hydroxydopamine lesions of DA neurons in 369 
SN [43]. The bias in profiles of VTA and SN neuronal activities is supposedly linked with DA cell 370 
loss in 5xFAD mice (Fig. 6, A, C). Evident correlation between the extent of DA cell loss in VTA 371 
(63%) and SN (48%), and beta activity increase in EEG from these areas (37% and 20%, 372 
respectively) in 5xFAD mice is in line with this suggestion (Fig. 2, C, D, grey bars in beta band). 373 
Partial DA cell loss is expected to invoke compensatory feed-back and feed-forward mechanisms 374 
[44]. Indeed, MC activation has been shown to initiate bursts in VTA neurons [45] effectively 375 
stimulating DA release in the cortex [46, 47]. This seems to be a vivid manifestation of a 376 
compensatory function of the MC-VTA networks in 5xFAD mice, which are characterized by 377 
depleted DAT in MC (Fig. 6, B, D) that is well known to initiate compensatory modifications in DA 378 
synapses [48]. 379 
 In our study, the functioning of networks formed by different brain areas was evaluated 380 
through the relations between their EEG frequency spectra (Fig. 2). In mice from both groups, the 381 
relative spectral profiles of EEG from HPC and MC were flat (Fig. 3, A). Thus, the slowing of 382 
 12 
EEGs from these areas in Tg mice (Fig. 2, A, B, grey bars) seems to be associated with 383 
synchronization of cortical and hippocampal oscillations that, in turn, may be correlated with the 384 
DAT level reduction observed in MC in 5xFAD mice (Fig. 6, B, D). Indeed, DA infusion into MC 385 
has been shown to produce a significant enhancement of EEG synchronization and/or coherence 386 
in MC and HPC [49]. Together, these suggest that DA transmission in the MC-HPC neuronal 387 
circuits in 5xFAD mice is unchanged.  388 
 In control mice, VTA recordings were characterized by increased higher delta-lower theta and 389 
decreased lower alpha-beta ranges (Fig. 2, C, grey line), that may be interpreted as a 390 
predominance of tonic discharges in VTA neurons and “bursting” activity in SN (see above). This 391 
specificity of DA-containing areas, revealed in their EEG spectral profiles, was lost in 5xFAD mice 392 
(Fig. 2, B, black line). Thus, the SN-VTA networks [50] in 5xFAD mice seem to be tuned to 393 
enhanced synchronization of the neuronal firing activity in the DA-producing nuclei. This is 394 
supposedly associated with the mechanisms, which are involved in the compensatory processes 395 
initiated by neuronal deficit in SN and VTA [51].  396 
 In 5xFAD mice, a significant attenuation of the spectral differences in EEG from DA nuclei and 397 
MC was observed throughout the analyzed frequency range (Fig. 3, C, D). Thus, the functional 398 
disturbances in 5xFAD mice seem to be predominantly associated with the attenuation of the 399 
oscillatory activity in their DA nuclei-forebrain networks.  400 
 Apomorphine effects 401 
 In control mice, APO produced a "desynchronising" effect in EEG from MC and HPC, with both 402 
attenuated delta and enhanced beta activities (Fig. 4, A - D, grey lines) similar to those observed 403 
in rats treated with APO at the same dose of 1.0 mg/kg [52]. At the lower dose of 0.01 mg/kg, 404 
APO has been shown to evoke EEG slowing biased to the delta range [38]. At high doses, APO 405 
activates postsynaptic DA receptors in terminal areas as DA release in the forebrain is completely 406 
blocked by APO at the level of the DA-producing nuclei through the activated autoreceptors [53]. 407 
Hence, a significant elevation of both suppression in delta band and activation in beta band in 408 
cortical and hippocampal EEG observed in 5xFAD mice (Fig. 4, A - D, black lines) might be 409 
explained by the increase in postsynaptic efficacy and/or enhanced sensitivity of DA receptors. 410 
Indeed, the neuronal population shrinkage in VTA and SN in 5xFAD mice (Fig. 6, A and C) is 411 
expected to result in chronic depletion of DA in the terminal areas of MC and HPC that in turn to 412 
initiate compensatory supersensitization of the postsynaptic DA receptors [54]. Similar APO 413 
effects in delta range of EEG from VTA and SN in mice from both groups (Fig. 4, E and G) 414 
underline a relatively high functional stability of basic mechanisms involved in tonic neuronal firing 415 
in these nuclei. On the other hand, significant differences revealed in beta ("bursting") range in 416 
VTA and SN between 5xFAD and nTg mice (Fig. 4, F and H) seem to be associated with the 417 
feed-back effects of the APO-activated forebrain on the DA-producing neurons in an attempt to 418 
compensate for their APO-suppressed bursting activity [45]. 419 
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 APO effects on the EEG spectra in mice from different groups are expressed in both frequency 420 
and brain area specific manner (Fig. 5) that might be associated with differences in regional 421 
sensitivity of DA receptors to APO. Indeed, delta activity, slightly suppressed by APO in MC of 422 
mice from both groups (Fig. 5, A, B, grey lines), is roughly affected by APO in VTA, while at lower 423 
extent in 5xFAD mice (Fig. 5, A, B, black lines). In contrast, APO enhancing of cortical beta 424 
activity, comparable in mice from both groups (Fig. 5, C, D, grey lines), is accompanied by a 425 
significant beta suppression in VTA, predominantly in 5xFAD mice (Fig. 5, C, D, black lines). 426 
Given the deficit of DA-producing neurones in 5xFAD mice (Fig. 6, A, C) these results might be 427 
concluded to be consistent with the suggestion that DA-ergic deprivation is accompanied by 428 
hypersensitization of post- and pre-synaptic DA receptors [54, 55]. Furthermore, the significant 429 
amplification of APO-induced delta activity in EEG from VTA in 5xFAD mice (c.f. Fig. 5, A and B, 430 
black lines) is seemingly associated with sensitization of post-synaptic receptors whereas the 431 
beta attenuation (c.f. Fig. 5, C and D, black lines) may be due to the pre-synaptic modifications. 432 
The differences revealed in APO effects on EEG from VTA in 5xFAD and nTg mice and 433 
similarities of those in MC (Fig. 5) might be explained by a regional selectivity of DA clearing 434 
mechanisms associated with predominant activity of either DAT or catechol-o-methyltransferase 435 
(in MC, in particular) [56]. Characteristic DAT levels in MC and DG, different in nTg mice and 436 
similar in Tg mice (Fig. 6, D), are indirectly consistent with this suggestion. DAT activity deficit is 437 
expected could be accompanied by an increase of DA level in the synaptic clefts that in turn 438 
might initiate a compensatory desensitization of both pre- and post-synaptic DA receptors [48]. 439 
Thus, the deficit of both DA-producing neurones and DAT in 5xFAD mice might be suggested to 440 
affect the DA receptors sensitivity resulting in compensatory reorganization of the neuronal 441 
networks in/within various brain areas. This is expected could lead to modifications of the APO 442 
effects on the EEG oscillations generated by the affected networks.  443 
In conclusion, the links between EEG spectra modifications and various intracerebral network 444 
transformations in the transgenic model of familial AD, 5xFAD mice, are analyzed in this work. 445 
We have shown that EEGs from dopamine-containing areas in the midbrain and in their terminal 446 
forebrain structures are altered in these animals. Associations of these alterations with shrinkage 447 
of DA-producing cell population, lowered dopamine transporter level, and modified sensitivity of 448 
dopamine receptors, which were revealed in this study, are discussed. We suggest that this EEG 449 
approach might be a useful tool for further studies of the adaptive/compensatory neuronal 450 
network remodelling associated with disturbances in the dopaminergic system. Regardless of the 451 
sources of these disturbances, in particular, associated with α-synuclein involvement [57], they 452 
are expected to shift the balance between neurogenesis [58] and senescence [59] towards the 453 
later, resulting in the neurodegenerative pathology. 454 
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Figures legends 622 
Figure 1. Typical patterns in 12-s fragments of baseline EEG in wakeful and behaviourally active 623 
non-transgenic (nTg) and 5xFAD (Tg) mice (A and B, respectively) and their frequency spectra 624 
(C - F) in the secondary motor cortex (MC), hippocampus (HPC), and the nuclei containing DA-625 
synthesizing neurons: substantia nigra (SN) and ventral tegmental area (VTA).  626 
 On A and B, time calibration is 1 sec, amplitude calibration is 100 V. On C - F, abscissa is a 627 
frequency subband marked with its mean value, in hertz; ordinate is summed amplitudes of EEG 628 
in each of 20 subbands, normalized to a sum of all amplitude values, in arbitrary units. Alternating 629 
white and grey bars indicate "classical" EEG frequency bands (from left to right): delta, theta, 630 
alpha, and beta. 631 
 632 
Figure 2. Averaged amplitude-frequency spectra of 12-s baseline EEG fragments recorded from 633 
MC (A), HPC (B), VTA (C), and SN (D) for 60 min in non-transgenic (nTg, n = 9) and 5xFAD (Tg, 634 
n = 6) mice (dashed and solid lines, respectively) and spectral ratios (narrow grey bars) between 635 
the groups (Tg/nTg).  636 
 Abscissa is a frequency subband marked with its mean value, in hertz; the left ordinate is 637 
summed absolute values of EEG amplitudes in each of 20 subbands, normalized to sum of all 638 
amplitude values, in arbitrary units; the right ordinate is a ratio of the EEG amplitudes, calculated 639 
as (Tg - nTg) / nTg, in %. Vertical lines are ±1SEM; diamond denotes a significant difference 640 
between the groups (p<0.05, Wilcoxon test). Alternating white and grey bars indicate "classical" 641 
EEG frequency bands (from left to right): delta, theta, alpha, and beta. 642 
 643 
Figure 3. Relations between averaged amplitude-frequency spectra of 12-s baseline EEG 644 
fragments recorded from the secondary motor cortex (MC), superficial layers of the 645 
hippocampal CA1 area (HPC), substantia nigra (SN), and ventral tegmental area (VTA) for 646 
60 min in non-transgenic (nTg, n = 9) and 5xFAD (Tg, n = 6) mice (dashed and solid lines, 647 
respectively). Abscissa is a frequency subband marked with its mean value in hertz; ordinate 648 
is a ratio of summed absolute values of baseline EEG amplitudes in each of 20 subbands, 649 
normalized to sum of all amplitudes of EEG recorded from different brain areas, calculated 650 
as (Area 1 - Area 2) / Area 2, in %, characterizing genetically determined EEG relations 651 
between them. Vertical lines are ±1SEM; diamond denotes a significant difference between 652 
the groups (p<0.05, Wilcoxon test). Alternating white and grey bars indicate "classical" EEG 653 
frequency bands (from left to right): delta, theta, alpha, and beta. 654 
 655 
Figure 4. Evolution of apomorphine (APO, 1.0 mg/kg, s.c.) vs. saline effects in delta and beta 656 
frequency bands (A, C, E, G and B, D, F, H, respectively) of EEG from MC, HPC, VTA, and SN in 657 
non-transgenic (nTg, n = 9) and 5xFAD (Tg, n = 6) mice (gray and black lines, respectively). 658 
 21 
Abscissa shows time after injection, marked in 10-min intervals. Ordinate is a ratio of the 659 
averaged EEG amplitudes in the indicated frequency bands, obtained in experiments with saline 660 
and APO in each group, and estimated as (APO - Saline) / Saline, in %, characterizing APO 661 
effects in nTg and Tg groups. A difference between baseline EEG ratios in Tg and nTg mice was 662 
used for normalization of APO effects in Tg group. Diamond denotes a significant difference 663 
between the groups (p < 0.05, Wilcoxon test). Error bars show ±1 SEM. 664 
 665 
Figure 5. Evolution of apomorphine (APO, 1.0 mg/kg, s.c.) effects in delta and beta bands of 666 
EEG from MC and VTA in non-transgenic (nTg) and 5xFAD mice (n = 9 and 6, respectively). 667 
Abscissa shows time after APO injection, marked in 10-min intervals. Ordinate is EEG amplitudes 668 
(in arbitrary units) summed in the indicated frequency bands in different brain areas separately for 669 
each group and normalized to EEG baseline values in MC (horizontal dashed lines). Diamond 670 
denotes a significant difference between the groups (p < 0.05, Wilcoxon test). Error bars show ±1 671 
SEM. 672 
 673 
Figure 6. Distribution of tyrosine hydroxylase immunopositive (TH+) cells (A, C) and dopamine 674 
transporter (DAT) (B, D) in different brain areas in non-transgenic (nTg) and transgenic (Tg, 675 
5xFAD) mice. On A, photomicrographs from nTg (a, b) and Tg (c, d) experimental mice display 676 
TH+ cells (black pyramids) in the ventral tegmental area (VTA) and the substantia nigra (SN), 677 
outlined by dashed ellipsis on the centered section, modified from [31]. On B, photomicrographs 678 
display DAT vesicles distributions (black spots) in the dentate gyrus (DG) from nTg (a) and Tg (b) 679 
experimental mice in the area outlined by open white rectangle. Obvious loss of TH-positive 680 
neurons and DAT vesicles is observed in 5xFAD mice. Horizontal white bars on A and B denote 681 
the scales of 50 µm. On C, abscissa demonstrates the brain areas with DA-producing neurons, 682 
VTA and SN; on D, abscissa shows the brain areas containing DAT: MC, DG, and hippocampal 683 
CA1-CA2, and CA3-CA4 fields. Ordinate on C is the number of TH-positive cells in the 684 
boundaries of VTA and SN; ordinate on D is the DAT-containing area (in mm2), accounted in the 685 
frame of 0.55 mm x 0.45 mm (0.25 mm2). Stars denote significant differences between Tg and 686 
nTg groups, ** – p < 0.01, *** – p < 0.001 (two-tailed U-test). 687 
688 
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